COVID-19 Associated Acute Pancreatitis: A Case Series from India.
Infect Disord Drug Targets
; 2022 May 30.
Article
in English
| MEDLINE | ID: covidwho-2281632
ABSTRACT
INTRODUCTION:
Initially, COVID-19 was typically concerned with respiratory symptoms and had a mild and asymptomatic to critical clinical course. Over time, many atypical presentations related to cardiac, hepatic, gastrointestinal, renal, musculoskeletal, and neurological features have been reported in COVID-19. CASE PRESENTATION We present three confirmed cases of COVID-19 who developed acute pancreatitis without any other obvious discernible cause. One middle-aged patient of 48-years old male presented with severe abdominal pain with mild symptoms, COVID-19, later diagnosed as acute pancreatitis with a positive outcome. Another 40-year-old male, hospitalized due to moderate COVID-19, developed acute pancreatitis and managed successfully. The third patient of 58 years old with control diabetes and severe COVID-19 developed acute necrotizing pancreatitis. Unfortunately, he succumbed due to multiorgan failure while on the mechanical ventilator.CONCLUSION:
Acute pancreatitis is uncommon in COVID-19. Although, it should be kept as a high index clinical suspicion if abdominal pain is reported. Early diagnosis and prompt management can significantly impact the patient's outcome.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Observational study
/
Prognostic study
Language:
English
Journal subject:
Communicable Diseases
/
Drug Therapy
Year:
2022
Document Type:
Article
Affiliation country:
1871526522666220530142359
Similar
MEDLINE
...
LILACS
LIS